4.7 Article

Simvastatin increases the in vivo activity of the first-line tuberculosis regimen

Related references

Note: Only part of the references are listed.
Article Microbiology

Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis

Shashank Gupta et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Review Microbiology

New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

Jossy van den Boogaard et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Review Medicine, General & Internal

Statins for the Prevention and Treatment of Infections A Systematic Review and Meta-analysis

Imad M. Tleyjeh et al.

ARCHIVES OF INTERNAL MEDICINE (2009)

Article Cardiac & Cardiovascular Systems

NPC1 repression contributes to lipid accumulation in human macrophages exposed to environmental aryl hydrocarbons

Normand Podechard et al.

CARDIOVASCULAR RESEARCH (2009)

Article Endocrinology & Metabolism

Simvastatin Protects against the Development of Endometriosis in a Nude Mouse Model

Kaylon L. Bruner-Tran et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Article Critical Care Medicine

Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome

Hendrik Schmidt et al.

INTENSIVE CARE MEDICINE (2006)

Article Respiratory System

The global alliance for tuberculosis drug development -: Accomplishments and future directions

CA Gardner et al.

CLINICS IN CHEST MEDICINE (2005)

Article Critical Care Medicine

The need for new drugs against tuberculosis - Obstacles, opportunities, and next steps

RJ O'Brien et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)